These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 24373579

  • 1. Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats.
    Ndumnego OC, Crafford J, Beyer W, van Heerden H.
    BMC Vet Res; 2013 Dec 27; 9():265. PubMed ID: 24373579
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC, Köhler SM, Crafford J, van Heerden H, Beyer W.
    Vet Immunol Immunopathol; 2016 Oct 01; 178():14-21. PubMed ID: 27496738
    [Abstract] [Full Text] [Related]

  • 3. Use of the mice passive protection test to evaluate the humoral response in goats vaccinated with Sterne 34F2 live spore vaccine.
    Phaswana PH, Ndumnego OC, Koehler SM, Beyer W, Crafford JE, van Heerden H.
    Vet Res; 2017 Sep 07; 48(1):46. PubMed ID: 28882176
    [Abstract] [Full Text] [Related]

  • 4. Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
    Parreiras PM, Sirota LA, Wagner LD, Menzies SL, Arciniega JL.
    Vaccine; 2009 Jul 16; 27(33):4537-42. PubMed ID: 19501205
    [Abstract] [Full Text] [Related]

  • 5. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S, Little S, Friedlander A, Fritz D, Fellows P.
    Microbiology (Reading); 2001 Jun 16; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [Abstract] [Full Text] [Related]

  • 6. Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity.
    Pittman PR, Fisher D, Quinn X, Schmader T, Barrera-Oro JG.
    Vaccine; 2013 Oct 17; 31(44):5009-14. PubMed ID: 24026013
    [Abstract] [Full Text] [Related]

  • 7. Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.
    Clement KH, Rudge TL, Mayfield HJ, Carlton LA, Hester A, Niemuth NA, Sabourin CL, Brys AM, Quinn CP.
    Clin Vaccine Immunol; 2010 Nov 17; 17(11):1753-62. PubMed ID: 20739500
    [Abstract] [Full Text] [Related]

  • 8. In vitro correlate of immunity in a rabbit model of inhalational anthrax.
    Pitt ML, Little SF, Ivins BE, Fellows P, Barth J, Hewetson J, Gibbs P, Dertzbaugh M, Friedlander AM.
    Vaccine; 2001 Sep 14; 19(32):4768-73. PubMed ID: 11535328
    [Abstract] [Full Text] [Related]

  • 9. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
    Li H, Soroka SD, Taylor TH, Stamey KL, Stinson KW, Freeman AE, Abramson DR, Desai R, Cronin LX, Oxford JW, Caba J, Pleatman C, Pathak S, Schmidt DS, Semenova VA, Martin SK, Wilkins PP, Quinn CP.
    J Immunol Methods; 2008 Apr 20; 333(1-2):89-106. PubMed ID: 18304568
    [Abstract] [Full Text] [Related]

  • 10. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
    Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N, AVRP Laboratory Working Group.
    Clin Vaccine Immunol; 2012 Nov 20; 19(11):1730-45. PubMed ID: 22933399
    [Abstract] [Full Text] [Related]

  • 11. Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.
    Pittman PR, Leitman SF, Oro JG, Norris SL, Marano NM, Ranadive MV, Sink BS, McKee KT.
    Clin Diagn Lab Immunol; 2005 Jun 20; 12(6):713-21. PubMed ID: 15939745
    [Abstract] [Full Text] [Related]

  • 12. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
    Dumas EK, Garman L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Choudhari S, Picking WD, James JA, Farris AD.
    Vaccine; 2017 Jun 08; 35(26):3416-3422. PubMed ID: 28504191
    [Abstract] [Full Text] [Related]

  • 13. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK, Gross T, Larabee J, Pate L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Collins LC, Spooner CE, Chen H, Ballard J, James JA, Farris AD.
    Clin Vaccine Immunol; 2017 Nov 08; 24(11):. PubMed ID: 28877928
    [Abstract] [Full Text] [Related]

  • 14. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.
    Dumas EK, Nguyen ML, Cox PM, Rodgers H, Peterson JL, James JA, Farris AD.
    Vaccine; 2013 Apr 03; 31(14):1856-63. PubMed ID: 23415781
    [Abstract] [Full Text] [Related]

  • 15. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R, Gupta PK, Banerjea AC, Singh Y.
    Vaccine; 2002 Jun 21; 20(21-22):2836-9. PubMed ID: 12034111
    [Abstract] [Full Text] [Related]

  • 16. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
    Semenova VA, Schiffer J, Steward-Clark E, Soroka S, Schmidt DS, Brawner MM, Lyde F, Thompson R, Brown N, Foster L, Fox S, Patel N, Freeman AE, Quinn CP.
    J Immunol Methods; 2012 Feb 28; 376(1-2):97-107. PubMed ID: 22197974
    [Abstract] [Full Text] [Related]

  • 17. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
    Koehler SM, Buyuk F, Celebi O, Demiraslan H, Doganay M, Sahin M, Moehring J, Ndumnego OC, Otlu S, van Heerden H, Beyer W.
    BMC Vet Res; 2017 Jul 12; 13(1):220. PubMed ID: 28701192
    [Abstract] [Full Text] [Related]

  • 18. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
    Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, Stamey K, Steward-Clark E, Schmidt DS, Mothershed E, Pruckler J, Schwartz S, Benson RF, Helsel LO, Holder PF, Johnson SE, Kellum M, Messmer T, Thacker WL, Besser L, Plikaytis BD, Taylor TH, Freeman AE, Wallace KJ, Dull P, Sejvar J, Bruce E, Moreno R, Schuchat A, Lingappa JR, Martin SK, Walls J, Bronsdon M, Carlone GM, Bajani-Ari M, Ashford DA, Stephens DS, Perkins BA.
    Emerg Infect Dis; 2002 Oct 12; 8(10):1103-10. PubMed ID: 12396924
    [Abstract] [Full Text] [Related]

  • 19. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.
    Taft SC, Weiss AA.
    Clin Vaccine Immunol; 2008 Jan 12; 15(1):71-5. PubMed ID: 18032590
    [Abstract] [Full Text] [Related]

  • 20. Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays.
    Brady RA, Verma A, Meade BD, Burns DL.
    Clin Vaccine Immunol; 2010 Sep 12; 17(9):1390-7. PubMed ID: 20631338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.